Introduction
INTERSTITIAL PNEUMONITIS, DISEASES, INFLAMMATORY DISEASE
While novel immunotherapeutic strategies play an important role in oncological and rheumatological diseases, their role in rare immune-mediated inflammatory diseases (IMIDs) with interstitial pneumonitis (IP) has only recently been addressed [